zilemaltib   Click here for help

GtoPdb Ligand ID: 13295

Synonyms: example 39 [WO2021134004A1] | SGR-1505 | SGR1505
Compound class: Synthetic organic
Comment: SGR-1505 is a clinical lead MALT1 allosteric inhibitor. Its chemical structure was revealed during the first time disclosures session at the 2024 ACS spring meeting in New Orleans. SGR-1505 is one of the structures claimed in patent WO2021134004 [1]. Discovery and chemical structure were formally disclosed by peer reviewed publication in October 2025 [3]. This structure was matched to that for the INN zilemaltib, as disclosed in WHO INN Proposed List 135 (July 2026).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 100.62
Molecular weight 481.79
XLogP 2.53
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@]1(CN(C2=C1N3C(=CC(=N3)F)N=C2)C(=O)NC4=CN=C(C(=C4)Cl)N5N=CC=N5)C(F)(F)F
Isomeric SMILES C[C@]1(CN(C(=O)NC2=CC(Cl)=C(N=C2)N3N=CC=N3)C4=C1N5N=C(F)C=C5N=C4)C(F)(F)F
InChI InChI=1S/C18H12ClF4N9O/c1-17(18(21,22)23)8-30(11-7-24-13-5-12(20)29-31(13)14(11)17)16(33)28-9-4-10(19)15(25-6-9)32-26-2-3-27-32/h2-7H,8H2,1H3,(H,28,33)/t17-/m1/s1
InChI Key DEMHKALZEXJNJH-QGZVFWFLSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
SGR-1505 is being developed by Schrodinger as a treatmet for solid tumours and haematological malignancies.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05544019 Study of SGR-1505 in Mature B-Cell Neoplasms Phase 1 Interventional Schrödinger, Inc.